PREVALENCE OF INTESTINAL PARASITISM AND ASSOCIATED SYMPTOMATOLOGY AMONG HEMODIALYSIS PATIENTS

Authors

  • Frederico F. Gil UFMG; ICB; Departamento de Parasitologia
  • Maxlene J. Barros Hospital Governador Israel Pinheiro, IPSEMG; Pós-Graduação em Ciências da Saúde
  • Nazaré A. Macedo Hospital Governador Israel Pinheiro, IPSEMG; Pós-Graduação em Ciências da Saúde
  • Carmelino G. E. Júnior Hospital Governador Israel Pinheiro, IPSEMG; Pós-Graduação em Ciências da Saúde
  • Roseli Redoan Hospital Governador Israel Pinheiro, IPSEMG; Pós-Graduação em Ciências da Saúde
  • Haendel Busatti UFMG; ICB; Departamento de Parasitologia
  • Maria A. Gomes UFMG; ICB; Departamento de Parasitologia
  • Joseph F. G. Santos Hospital Governador Israel Pinheiro, IPSEMG; Pós-Graduação em Ciências da Saúde

Keywords:

Enteroparasitosis, Hemodialysis patients, Symptoms

Abstract

;Intestinal parasites are an important cause of morbidity and mortality. Immunocompromised individuals may develop more severe forms of these infections. Taking into account the immunity impairment in patients suffering from chronic renal failure (CRF), we will determine the prevalence and associated symptoms of intestinal parasites in these patients. Controls without CRF were used for comparison. Stool samples were collected and processed for microscopic identification of parasites using the Formalin-ether concentration method. For Cryptosporidium diagnosis, the ELISA technique was used. One hundred and ten fecal samples from hemodialysis patients were analyzed, as well as 86 from a community group used as control group. A result of 51.6% of intestinal parasites was observed in hemodialysis patients and 61.6% in the control group. Cryptosporidium and Blastocystis were the most common infections in patients with CRF (26.4% and 24.5%, respectively). Blastocystis was the most common infection in the control group (41.9%), however no individual was found positive for Cryptosporidium. Among the CRF patients, 73.6% were symptomatic, 54.3% of these tested positive for at least one parasite, in contrast to 44.8% in asymptomatic patients (p = 0.38). The most common symptoms in this group were flatulence (36.4%), asthenia (30.0%) and weight loss (30.0%). In the control group, 91.9% were symptomatic, 60.8% of these tested positive for at least one parasite, in contrast to 71.4% in asymptomatic patients (p = 0.703). A significant difference between the two groups was observed with regard to symptoms, with bloating, postprandial fullness, and abdominal pain being more frequent in the control group than in the hemodialysis group (all p < 0.05). Comparing symptomatic with asymptomatic, there was no association in either group between symptoms or the prevalence of parasitic infection, nor with the type of parasite or with multiple parasitic infections. Patients with chronic renal failure are frequent targets for renal transplantation, which as well as the inherent immunological impairment of the disease itself, results in immunosuppression by medication. For this reason, carriers of intestinal parasites with pathogenic potential can develop serious clinical complications influencing the success of transplantation. This fact, coupled with the high prevalence of intestinal parasites and the dissociation between symptoms and infection in CRF patients, suggests that the stool test should be incorporated in routine propedeutics. Furthermore, preventive measures for the acquisition of parasites through the fecal-oral contamination route should be introduced.

Downloads

Download data is not yet available.

Downloads

Published

2013-04-01

Issue

Section

Parasitology

How to Cite

PREVALENCE OF INTESTINAL PARASITISM AND ASSOCIATED SYMPTOMATOLOGY AMONG HEMODIALYSIS PATIENTS. (2013). Revista Do Instituto De Medicina Tropical De São Paulo, 55(2), 69-74. https://www.revistas.usp.br/rimtsp/article/view/53543